ArticleBiopolymers2026
Untreated Rosehip Powder/Poly(Lactic Acid)/Poly(3-Hydroxybutyrate-Co-4-Hydroxybutyrate) Electrospun Mats for Wound Dressing Applications.
Article in Biopolymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study investigated the effects of directly incorporating untreated rosehip (RoHi) powder into electrospun poly(lactic acid)/poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (PLA/P(3HB-co-4HB)) (70/30, w/w) blends, focusing on the structural, morphological, mechanical, wettability, and biological properties of resulting nanofibrous mats. The average fiber diameter of pure nanofibers was 776 nm, while RoHi addition resulted in diameters ranging from 468 nm (1% RoHi) to 1496 nm (5% RoHi). FTIR analysis confirmed that the characteristic functional groups of RoHi were preserved within the polymer matrix without chemical interaction. The water contact angle decreased from 136.45° for the pure mat to 116.11° for nanofibers containing 5% RoHi, leading to an increase in liquid adsorption capacity from 1.49% to 249.38%. Cytotoxicity results demonstrated that all samples were biocompatible, with the highest cell viability (148.91%) observed for nanofibers containing 1% RoHi. In vitro scratch assays revealed enhanced fibroblast migration for RoHi-containing nanofibers, particularly within the first 24 h, with the fastest wound closure observed at 3% and 5% RoHi contents. DPPH analysis showed increased antioxidant activity from 27.68% to 63.84%, whereas no antibacterial activity was detected against Staphylococcus aureus and Pseudomonas aeruginosa. Overall, RoHi-doped nanofibers exhibit promising potential as wound dressing materials considered suitable for use in chronic wounds due to their antioxidant activity and bio-responsive wound-healing performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.